Dr.Finance Past Earnings Performance

Past criteria checks 0/6

Dr.Finance's earnings have been declining at an average annual rate of -59.1%, while the Capital Markets industry saw earnings growing at 31.6% annually. Revenues have been growing at an average rate of 0.5% per year.

Key information

-59.1%

Earnings growth rate

-59.1%

EPS growth rate

Capital Markets Industry Growth9.4%
Revenue growth rate0.5%
Return on equity-115.0%
Net Margin-2.7%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Dr.Finance makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

WSE:DRF Revenue, expenses and earnings (PLN Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24110100
30 Jun 249090
31 Mar 248080
31 Dec 236060
30 Sep 234040
30 Jun 234040
31 Mar 235050
31 Dec 227070
30 Sep 22100100
30 Jun 22120110
31 Mar 22130120
31 Dec 21120110
30 Sep 21100100
30 Jun 219080
31 Mar 218080
31 Dec 208070
30 Sep 207070
30 Jun 207070
31 Mar 207070
31 Dec 197070
30 Sep 197060
30 Jun 196060
31 Mar 195050
31 Dec 185050
30 Sep 185140
30 Jun 185150
31 Mar 185050
31 Dec 176050
30 Sep 176050
30 Jun 176050
31 Mar 176050
31 Dec 166050
30 Sep 165050
30 Jun 165050
31 Mar 165040
31 Dec 154040
30 Sep 154040
30 Jun 155-140
31 Mar 156-150
31 Dec 147-270
30 Sep 1410-190
30 Jun 1412-1100
31 Mar 1412-1110
31 Dec 13150130

Quality Earnings: DRF is currently unprofitable.

Growing Profit Margin: DRF is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: DRF is unprofitable, and losses have increased over the past 5 years at a rate of 59.1% per year.

Accelerating Growth: Unable to compare DRF's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: DRF is unprofitable, making it difficult to compare its past year earnings growth to the Capital Markets industry (8.6%).


Return on Equity

High ROE: DRF has a negative Return on Equity (-114.98%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 09:31
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Dr.Finance S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution